168 related articles for article (PubMed ID: 24579925)
1. Histopathologic features of transplant glomerulopathy associated with response to therapy with intravenous immune globulin and rituximab.
Kahwaji J; Najjar R; Kancherla D; Villicana R; Peng A; Jordan S; Vo A; Haas M
Clin Transplant; 2014 May; 28(5):546-53. PubMed ID: 24579925
[TBL] [Abstract][Full Text] [Related]
2. Clinical and pathological analyses of transplant glomerulopathy cases.
Shimizu T; Ishida H; Toki D; Nozaki T; Omoto K; Tanabe K; Honda K; Koike J
Nephrology (Carlton); 2014 Jun; 19 Suppl 3():21-6. PubMed ID: 24842817
[TBL] [Abstract][Full Text] [Related]
3. Intravenous immunoglobulins and rituximab therapy for severe transplant glomerulopathy in chronic antibody-mediated rejection: a pilot study.
Bachelet T; Nodimar C; Taupin JL; Lepreux S; Moreau K; Morel D; Guidicelli G; Couzi L; Merville P
Clin Transplant; 2015 May; 29(5):439-46. PubMed ID: 25739833
[TBL] [Abstract][Full Text] [Related]
4. Comparison between bortezomib and rituximab in the treatment of antibody-mediated renal allograft rejection.
Waiser J; Budde K; Schütz M; Liefeldt L; Rudolph B; Schönemann C; Neumayer HH; Lachmann N
Nephrol Dial Transplant; 2012 Mar; 27(3):1246-51. PubMed ID: 21852274
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological analysis of transplant glomerulopathy cases.
Shimizu T; Ishida H; Shirakawa H; Omoto K; Tsunoyama K; Iida S; Tanabe K; Yamaguchi Y
Clin Transplant; 2009 Aug; 23 Suppl 20():39-43. PubMed ID: 19594595
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcome in patients with chronic antibody-mediated rejection treated with and without rituximab and intravenous immunoglobulin combination therapy.
Chung BH; Kim Y; Jeong HS; Hong YA; Choi BS; Park CW; Choi YJ; Kim YS; Yang CW
Transpl Immunol; 2014 Sep; 31(3):140-4. PubMed ID: 25179826
[TBL] [Abstract][Full Text] [Related]
7. Benefits of rituximab combined with intravenous immunoglobulin for desensitization in kidney transplant recipients.
Vo AA; Choi J; Cisneros K; Reinsmoen N; Haas M; Ge S; Toyoda M; Kahwaji J; Peng A; Villicana R; Jordan SC
Transplantation; 2014 Aug; 98(3):312-9. PubMed ID: 24770617
[TBL] [Abstract][Full Text] [Related]
8. Impact of rituximab therapy for treatment of acute humoral rejection.
Kaposztas Z; Podder H; Mauiyyedi S; Illoh O; Kerman R; Reyes M; Pollard V; Kahan BD
Clin Transplant; 2009; 23(1):63-73. PubMed ID: 19200217
[TBL] [Abstract][Full Text] [Related]
9. Treatment of chronic antibody mediated rejection with intravenous immunoglobulins and rituximab: A multicenter, prospective, randomized, double-blind clinical trial.
Moreso F; Crespo M; Ruiz JC; Torres A; Gutierrez-Dalmau A; Osuna A; Perelló M; Pascual J; Torres IB; Redondo-Pachón D; Rodrigo E; Lopez-Hoyos M; Seron D
Am J Transplant; 2018 Apr; 18(4):927-935. PubMed ID: 28949089
[TBL] [Abstract][Full Text] [Related]
10. The impact of C4d and microvascular inflammation before we knew them.
Verghese P; Dunn T; Najafian B; Kim Y; Matas A
Clin Transplant; 2013; 27(3):388-96. PubMed ID: 23528049
[TBL] [Abstract][Full Text] [Related]
11. Histologic phenotype on 1-year posttransplantation biopsy and allograft survival in HLA-incompatible kidney transplants.
Sharif A; Kraus ES; Zachary AA; Lonze BE; Nazarian SM; Segev DL; Alachkar N; Arend LJ; Bagnasco SM; Racusen LC; Montgomery RA
Transplantation; 2014 Mar; 97(5):541-7. PubMed ID: 24521779
[TBL] [Abstract][Full Text] [Related]
12. Clinical and pathological analysis of transplant glomerulopathy cases.
Shimizu T; Tanabe T; Shirakawa H; Omoto K; Ishida H; Tanabe K
Clin Transplant; 2012 Jul; 26 Suppl 24():37-42. PubMed ID: 22747474
[TBL] [Abstract][Full Text] [Related]
13. Morphologic patterns and treatment of transplant glomerulopathy: A retrospective analysis.
Abreu R; Carvalho F; Viana H; Mesquita I; Possante M; Aires I; Caeiro F; Silva C; Cotovio P; Ferreira A; Remédio F; Nolasco F
Clin Transplant; 2017 Apr; 31(4):. PubMed ID: 28135784
[TBL] [Abstract][Full Text] [Related]
14. Successful kidney transplantation after desensitization using plasmapheresis, low-dose intravenous immunoglobulin, and rituximab in highly sensitized patients: a single-center experience.
Jin MK; Cho JH; Kwon O; Hong KD; Choi JY; Yoon SH; Park SH; Kim YL; Kim CD
Transplant Proc; 2012 Jan; 44(1):200-3. PubMed ID: 22310614
[TBL] [Abstract][Full Text] [Related]
15. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological analysis of acute vascular rejection cases after renal transplantation.
Shimizu T; Ishida H; Shirakawa H; Omoto K; Tsunoyama K; Tokumoto T; Tanabe K
Clin Transplant; 2010 Jul; 24 Suppl 22():22-6. PubMed ID: 20590689
[TBL] [Abstract][Full Text] [Related]
17. Rituximab and intravenous immunoglobulin treatment of chronic antibody-mediated kidney allograft rejection.
Fehr T; Rüsi B; Fischer A; Hopfer H; Wüthrich RP; Gaspert A
Transplantation; 2009 Jun; 87(12):1837-41. PubMed ID: 19543061
[TBL] [Abstract][Full Text] [Related]
18. Molecular signatures and clinical outcomes of transplant glomerulopathy stratified by microvascular inflammation and donor-specific antibody.
Lubetzky M; Hayde N; Ó Broin P; Ajaimy M; Bao Y; Mohammed O; Schwartz D; Pullman J; Akalin E
Clin Transplant; 2019 Mar; 33(3):e13469. PubMed ID: 30578675
[TBL] [Abstract][Full Text] [Related]
19. Morphologic Features and Clinical Impact of Arteritis Concurrent with Transplant Glomerulopathy.
Dobi D; Bodó Z; Kemény É; Boda K; Szenohradszky P; Szederkényi E; Laszik ZG; Iványi B
Pathol Oncol Res; 2016 Jan; 22(1):15-25. PubMed ID: 26202171
[TBL] [Abstract][Full Text] [Related]
20. Transplant glomerulopathy: risk and prognosis related to anti-human leukocyte antigen class II antibody levels.
Issa N; Cosio FG; Gloor JM; Sethi S; Dean PG; Moore SB; DeGoey S; Stegall MD
Transplantation; 2008 Sep; 86(5):681-5. PubMed ID: 18791449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
